(0.23%) 5 111.88 points
(0.33%) 38 368 points
(0.27%) 15 972 points
(-1.32%) $82.74
(6.34%) $2.05
(-0.05%) $2 346.10
(-0.21%) $27.48
(3.94%) $958.40
(-0.22%) $0.933
(-0.31%) $10.99
(-0.54%) $0.796
(1.65%) $93.39
Live Chart Being Loaded With Signals
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform...
Stats | |
---|---|
Dagens volum | 1.42M |
Gjennomsnittsvolum | 1.94M |
Markedsverdi | 1.77B |
EPS | $0 ( 2024-04-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 66.67 |
ATR14 | $0.381 (1.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | O'connor Daniel J. | Buy | 750 000 | Common Stock |
2023-10-27 | O'connor Daniel J. | Sell | 50 012 | Common Stock |
2023-10-23 | Cormorant Asset Management, Lp | Buy | 1 307 311 | Common Stock |
2023-09-18 | Cormorant Asset Management, Lp | Buy | 751 233 | Ordinary Shares |
2023-09-15 | Cormorant Asset Management, Lp | Buy | 1 401 505 | Ordinary Shares |
INSIDER POWER |
---|
64.17 |
Last 64 transactions |
Buy: 36 374 710 | Sell: 11 079 608 |
Volum Korrelasjon
Ambrx Biopharma Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
MSP | 0.95 |
RXN | 0.934 |
UVE | 0.934 |
MOG-B | 0.927 |
KDMN | 0.925 |
DCT | 0.922 |
WST | 0.921 |
AIW | 0.918 |
BGSX | 0.915 |
FCN | 0.914 |
10 Mest negative korrelasjoner | |
---|---|
LUMN | -0.94 |
KT | -0.934 |
AFI | -0.926 |
QGEN | -0.924 |
GEO | -0.92 |
NSC | -0.917 |
EQC | -0.912 |
UBA | -0.907 |
ATTO | -0.907 |
PDS | -0.906 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Ambrx Biopharma Inc. Korrelasjon - Valuta/Råvare
Ambrx Biopharma Inc. Økonomi
Annual | 2022 |
Omsetning: | $7.40M |
Bruttogevinst: | $7.40M (100.00 %) |
EPS: | $-2.02 |
FY | 2022 |
Omsetning: | $7.40M |
Bruttogevinst: | $7.40M (100.00 %) |
EPS: | $-2.02 |
FY | 2021 |
Omsetning: | $7.46M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.36 |
FY | 2020 |
Omsetning: | $13.67M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.439 |
Financial Reports:
No articles found.
Ambrx Biopharma Inc.
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer. The company is also developing two earlier-stage product candidates, including ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for the treatment of prostate cancer and other solid tumors; and ARX305, an anti-CD70 ADC in investigational new drug-enabling studies for the treatment of renal cell carcinoma and other cancers. In addition, it is developing other multiple product candidates targeting immuno-oncology applications, which include ARX822, a fab-small molecule bispecific that is in preclinical development for cancers; and ARX102, an immuno-oncology IL-2 pathway agonist to stimulate the patient's own immune system by targeting the ß and gamma receptors on the cytotoxic T cell. Ambrx Biopharma Inc. has collaborations with Bristol Myers Squibb Company; AbbVie Inc.; BeiGene; Sino Biopharmaceutical Co., Ltd.; NovoCodex; and Elanco Animal Health. The company was incorporated in 2003 and is headquartered in La Jolla, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.